ES557630A0 - Procedimiento para preparar dihidropiridinas - Google Patents

Procedimiento para preparar dihidropiridinas

Info

Publication number
ES557630A0
ES557630A0 ES557630A ES557630A ES557630A0 ES 557630 A0 ES557630 A0 ES 557630A0 ES 557630 A ES557630 A ES 557630A ES 557630 A ES557630 A ES 557630A ES 557630 A0 ES557630 A0 ES 557630A0
Authority
ES
Spain
Prior art keywords
procedure
preparing dihydropyridines
dihydropyridines
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557630A
Other languages
English (en)
Other versions
ES8802496A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES8802496A1 publication Critical patent/ES8802496A1/es
Publication of ES557630A0 publication Critical patent/ES557630A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES557630A 1985-02-11 1987-07-16 Procedimiento para preparar dihidropiridinas Expired ES8802496A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503425A GB8503425D0 (en) 1985-02-11 1985-02-11 Alkanolamine derivatives

Publications (2)

Publication Number Publication Date
ES8802496A1 ES8802496A1 (es) 1988-07-01
ES557630A0 true ES557630A0 (es) 1988-07-01

Family

ID=10574270

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551844A Expired ES8802139A1 (es) 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas.
ES557630A Expired ES8802496A1 (es) 1985-02-11 1987-07-16 Procedimiento para preparar dihidropiridinas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551844A Expired ES8802139A1 (es) 1985-02-11 1986-02-11 Procedimiento para preparar dihidropiridinas.

Country Status (21)

Country Link
US (1) US4873254A (es)
EP (1) EP0194751B1 (es)
JP (1) JPH0819100B2 (es)
KR (1) KR860006443A (es)
AU (1) AU5339486A (es)
CS (1) CS273172B2 (es)
DD (1) DD250533A5 (es)
DE (1) DE3684803D1 (es)
DK (1) DK66186A (es)
ES (2) ES8802139A1 (es)
FI (1) FI860621A7 (es)
GB (2) GB8503425D0 (es)
GR (1) GR860369B (es)
HU (1) HU196179B (es)
NO (1) NO860465L (es)
NZ (1) NZ215083A (es)
PH (1) PH22683A (es)
PL (2) PL153857B1 (es)
PT (1) PT82008B (es)
SU (1) SU1590041A3 (es)
ZA (1) ZA86967B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6112662A (ja) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体及びその製法
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation
WO2000005209A1 (fr) * 1998-07-23 2000-02-03 Lin, Tong-Ho GUAIACOXYPROPANOLAMINES A ACTIVITE α/β-ADRENOLYTIQUE
AR070950A1 (es) * 2007-11-01 2010-05-19 Acucela Inc Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
JPS6112662A (ja) * 1984-06-28 1986-01-21 Yamanouchi Pharmaceut Co Ltd ジヒドロピリジン誘導体及びその製法

Also Published As

Publication number Publication date
PL153857B1 (en) 1991-06-28
SU1590041A3 (ru) 1990-08-30
ES8802139A1 (es) 1988-04-01
JPS61233669A (ja) 1986-10-17
CS273172B2 (en) 1991-03-12
ZA86967B (en) 1986-11-26
GB8602704D0 (en) 1986-03-12
AU5339486A (en) 1986-08-14
GR860369B (en) 1986-06-02
EP0194751B1 (en) 1992-04-15
KR860006443A (ko) 1986-09-11
DK66186A (da) 1986-08-12
ES551844A0 (es) 1988-04-01
EP0194751A1 (en) 1986-09-17
HUT40415A (en) 1986-12-28
FI860621A0 (fi) 1986-02-11
NZ215083A (en) 1989-10-27
US4873254A (en) 1989-10-10
FI860621A7 (fi) 1986-08-12
PT82008B (pt) 1988-07-01
PL257902A1 (en) 1988-03-03
DD250533A5 (de) 1987-10-14
NO860465L (no) 1986-08-12
GB8503425D0 (en) 1985-03-13
DE3684803D1 (de) 1992-05-21
PL265252A1 (en) 1988-06-09
ES8802496A1 (es) 1988-07-01
DK66186D0 (da) 1986-02-11
HU196179B (en) 1988-10-28
PT82008A (en) 1986-03-01
CS91186A2 (en) 1990-07-12
PH22683A (en) 1988-11-14
PL149828B1 (en) 1990-03-31
JPH0819100B2 (ja) 1996-02-28

Similar Documents

Publication Publication Date Title
ES557241A0 (es) Procedimiento para preparar nuevos 2-aril-imidazoles
ES557211A0 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES553989A0 (es) Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
MX159506A (es) Procedimiento para preparar acidos quinolincarboxilicos
ES557693A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES551843A0 (es) Procedimiento para preparar dihidropiridinas.
ES549975A0 (es) Procedimiento para preparar n-formil-&-aspartil fenilalanina
ES555562A0 (es) Procedimiento para preparar celalosporinas
ES554112A0 (es) Procedimiento para preparar compuestos de ciclohexil y cicloexenil-imidazol
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES551847A0 (es) Procedimiento para preparar dihidropiridinas.
ES551844A0 (es) Procedimiento para preparar dihidropiridinas.
ES551845A0 (es) Procedimiento para preparar dihidropiridinas.
MX162329A (es) Procedimiento para preparar acilhidrazonas sulfeniladas
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES557615A0 (es) Procedimiento para preparar disulfuros heterociclicos
MX159907A (es) Procedimiento para preparar cloro-o-nitroanilinas
ES555042A0 (es) Procedimiento para preparar diazepinoindoles

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506